C12N 2750/10052
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2750/10052 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 4 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 7
- Assignees
- 5
- Inventors
- 17
- Latest grant
- 27 Aug 2013
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Production of homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection27 Aug 2013US 8,518,696 B2Temasek Life Sciences Laboratory Limited
- Methods to culture circovirus14 Jul 2009US 7,560,278 B2University of Saskatchewan
- Methods to culture circovirus6 Feb 2007US 7,172,899 B2University of Saskatchewan
- Methods to culture circovirus21 Sep 2004US 6,794,163 B2University of Saskatchewan
- Self-replicating dna expression system and immunogen17 Oct 2024US 2024/0344100 A1
- Recombinant circovirus capsid-virus-like particle (vlp): compositions, methods and uses9 Jun 2022US 2022/0177855 A1Huvepharma
- Cell-based methods and reagents27 Jun 2013US 2013/0164329 A1Alnylam Pharmaceuticals, Inc.
- Production of Homogeneous Cell Line Highly Permissive To Porcine Circovirus Type 2 (PCV2) Infection13 Jan 2011US 2011/0008871 A1Temasek Life Sciences Laboratory Limited
- Methods to culture circovirus7 Jun 2007US 2007/0128700 A1University of Saskatchewan
Most cited
By later US patents